The predictive value of serum SCUBE1, CLEC-2 and UCP2 in acute ischemic stroke after intravenous thrombolysis
Serum SCUBE1, CLEC-2 and UCP2 in acute ischemic stroke
Abstract
Objective: To analyze the predictive value of serum signal peptide-CUB-epidermal growth factor domain-containing protein 1 (SCUBE1), C-type lectin-like receptor-2 (CLEC-2), and uncoupling protein 2 (UCP2) for poor outcome following intravenous thrombolysis (IVT) in patients who have experienced an acute ischemic stroke (AIS).
Methods: A total of 116 AIS patients who received IVT treatment in this hospital from June 2023 to October 2024 were selected as the observation group, and the control group consisted of an additional 116 healthy people who were examined physically in this institution over the same time period. The patients were divided into good prognosis and poor prognosis groups according to the modified Rankin scale (mRS) score. After IVT, the factors predicting poor outcome in AIS patients were examined using multivariate logistic regression. The prognostic significance of serum SCUBE1, CLEC-2, and UCP2 for poor prognosis in AIS patients following IVT was examined using a receiver operating characteristic (ROC) curve.
Results: While the observation group's serum UCP2 level was lower than the control group's, the observation group's levels of SCUBE1 and CLEC-2 were higher. P<0.05 indicated that the differences were statistically significant. There were 75 patients in the good prognosis group and 41 patients in the poor prognosis group. While serum UCP2 levels were lower than those in the good prognosis group (P<0.05), the percentage of patients with infarction regions >4 cm³ and the levels of serum SCUBE1 and CLEC-2 were higher in the bad prognosis group than in the good prognosis group. According to multivariate logistic regression analysis, increased blood levels of SCUBE1 and CLEC-2 were associated with a poor prognosis for AIS patients following IVT (P<0.05), and higher blood UCP2 levels were protective factors against a poor outcome in AIS patients following IVT (P<0.05). The areas under the curve (AUCs) of serum SCUBE1, CLEC-2, and UCP2 alone for predicting a poor prognosis were found by the ROC curve analysis after IVT in AIS patients were 0.752, 0.694, and 0.776. SCUBE1, CLEC-2, and UCP2 had lower AUCs than the three indicators together, which had an AUC of 0.861. The AUC predicted separately (Z(3-item combination -SCUBE1)=2.358, Z(3-item combination -CLEC-2) =2.714, z 3-item combination -UCP2=2.591, P=0.018, 0.007, 0.010).
Conclusion: The levels of serum SCUBE1 and CLEC-2 in AIS patients with poor prognosis after IVT increase, whereas the level of UCP2 decreases. The combined detection of these three indicators has high predictive value for the poor prognosis of AIS patients after IVT.
References
2.Ghannam M, AlMajali M, Galecio-Castillo M, Al Qudah A, Khasiyev F, Dibas M, Ghazaleh D, Vivanco-Suarez J, Morán-Mariños C, Farooqui M, Rodriguez-Calienes A, Koul P, Roeder H, Shim H, Samaniego E, Leira EC, Adams HP Jr, Ortega-Gutierrez S. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2023 Dec 19;12(24):e031669. doi: 10.1161/JAHA.123.031669. Epub 2023 Dec 18. PMID: 38108256; PMCID: PMC10863770.
3.Ma F, Li L, Xu L, Wu J, Zhang A, Liao J, Chen J, Li Y, Li L, Chen Z, Li W, Zhu Q, Zhu Y, Wu M. The relationship between systemic inflammation index, systemic immune-inflammatory index, and inflammatory prognostic index and 90-day outcomes in acute ischemic stroke patients treated with intravenous thrombolysis. J Neuroinflammation. 2023 Sep 30;20(1):220. doi: 10.1186/s12974-023-02890-y. PMID: 37777768; PMCID: PMC10543872.
4.Shi H, Hou MM, Ren G, He ZF, Liu XL, Li XY, Sun B. Tirofiban for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2023;52(5):587-596. doi: 10.1159/000527861. Epub 2022 Dec 29. PMID: 36580906.
5.Al-Ajlan FS, Alkhiri A, Alamri AF, Alghamdi BA, Almaghrabi AA, Alharbi AR, Alansari N, Almilibari AZ, Hussain MS, Audebert HJ, Grotta JC, Shuaib A, Saver JL, Alhazzani A. Golden Hour Intravenous Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Ann Neurol. 2024 Sep;96(3):582-590. doi: 10.1002/ana.27007. Epub 2024 Jun 25. PMID: 38922985.
6.Meyne J, Domschikowski M, Hensler J, Helmers AK, Berg D, Deuschl G, Paschen S. Intravenous thrombolysis and mechanical recanalization for acute ischemic stroke in deep brain stimulation patients: a case series. J Neurol. 2023 Sep;270(9):4354-4359. doi: 10.1007/s00415-023-11765-4. Epub 2023 May 22. PMID: 37217758; PMCID: PMC10421811.
7.Psychogios K, Tsivgoulis G. Intravenous thrombolysis for acute ischemic stroke: why not? Curr Opin Neurol. 2022 Feb 1;35(1):10-17. doi: 10.1097/WCO.0000000000001004. PMID: 34799512.
8.Bao Q, Wu X, Li Y, Chen S, Zhang Q, Yang M, Yang P. Intravenous thrombolysis in acute ischemic stroke patients with prestroke disability: A systematic review and meta-analysis. Brain Behav. 2024 Feb;14(2):e3431. doi: 10.1002/brb3.3431. PMID: 38361315; PMCID: PMC10869883.
9.Sperring CP, Savage WM, Argenziano MG, Leifer VP, Alexander J, Echlov N, Spinazzi EF, Connolly ES Jr. No-Reflow Post-Recanalization in Acute Ischemic Stroke: Mechanisms, Measurements, and Molecular Markers. Stroke. 2023 Sep;54(9):2472-2480. doi: 10.1161/STROKEAHA.123.044240. Epub 2023 Aug 3. PMID: 37534511.
10.Gajurel BP, Nepal G, Jaiswal V, Ang SP, Nain P, Shama N, Ruchika FNU, Bohara S, Kharel S, Yadav JK, Medina JRT, Shrestha AB. Utilization rates of intravenous thrombolysis for acute ischemic stroke in Asian countries:: A systematic review and meta-analysis. Medicine (Baltimore). 2023 Oct 20;102(42):e35560. doi: 10.1097/MD.0000000000035560. PMID: 37861564; PMCID: PMC10589571.
11.Wu L, Zheng Y, Liu J, Luo R, Wu D, Xu P, Wu D, Li X. Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19. Aging (Albany NY). 2021 Apr 20;13(8):10833-10852. doi: 10.18632/aging.202860. Epub 2021 Apr 20. PMID: 33879634; PMCID: PMC8109137.
12.Gajurel BP, Nepal G, Jaiswal V, Ang SP, Nain P, Shama N, Ruchika FNU, Bohara S, Kharel S, Yadav JK, Medina JRT, Shrestha AB. Utilization rates of intravenous thrombolysis for acute ischemic stroke in Asian countries:: A systematic review and meta-analysis. Medicine (Baltimore). 2023 Oct 20;102(42):e35560. doi: 10.1097/MD.0000000000035560. PMID: 37861564; PMCID: PMC10589571.
13.Zheng M, Li L, Chen L, Li B, Feng C. Mechanical thrombectomy combined with intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analyses. Sci Rep. 2023 May 26;13(1):8597. doi: 10.1038/s41598-023-35532-7. PMID: 37237159; PMCID: PMC10220222.
14.Kristoffersen ES, Seiffge DJ, Meinel TR. Intravenous thrombolysis and mechanical thrombectomy in acute stroke patients on direct oral anticoagulants. J Neurol. 2024 Dec 21;272(1):82. doi: 10.1007/s00415-024-12832-0. PMID: 39708167; PMCID: PMC11663162.
15.Wu L, Zhong Y, Wu D, Xu P, Ruan X, Yan J, Liu J, Li X. Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines. 2022 Sep 10;10(9):2248. doi: 10.3390/biomedicines10092248. PMID: 36140350; PMCID: PMC9496572.
16.Bakola E, Giannopoulos S. Intravenous thrombolysis for acute ischemic stroke in COVID-19 era: Still the same? Acta Neurol Scand. 2022 Feb;145(2):125-126. doi: 10.1111/ane.13545. PMID: 34978072.
17.Ghaith HS, Elfil M, Gabra MD, Nawar AA, Abd-Alkhaleq MS, Hamam KM, Aboelnasr LE, Elgezery EA, Osman MH, Elsayed H, Swed S, Kanmounye US, Negida A. Intravenous thrombolysis before mechanical thrombectomy for acute ischemic stroke due to large vessel occlusion; should we cross that bridge? A systematic review and meta-analysis of 36,123 patients. Neurol Sci. 2022 Nov;43(11):6243-6269. doi: 10.1007/s10072-022-06283-6. Epub 2022 Jul 23. PMID: 35871179.
18.Marto JP, Kauppila LA, Jorge C, Faustino P, Sargento-Freitas J, Pereira L, Galego S, Dias R, Castro P, Pinho-E-Melo T, Fonseca AC. Acute Myocardial Infarction after Intravenous Thrombolysis for Acute Ischemic Stroke: Case Series and Systematic Review. J Stroke Cerebrovasc Dis. 2022 Feb;31(2):106244. doi: 10.1016/j.jstrokecerebrovasdis.2021.106244. Epub 2021 Dec 13. PMID: 34915306.
19.Wu L, Liu Q, Ruan X, Luan X, Zhong Y, Liu J, Yan J, Li X. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD). Biomedicines. 2023 Jun 29;11(7):1861. doi: 10.3390/biomedicines11071861. PMID: 37509501; PMCID: PMC10377220.
20.Knapen RRMM, Frol S, van Kuijk SMJ, Oblak JP, van der Leij C, van Oostenbrugge RJ, van Zwam WH. Intravenous thrombolysis for ischemic stroke in the posterior circulation: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2024 May;33(5):107641. doi: 10.1016/j.jstrokecerebrovasdis.2024.107641. Epub 2024 Feb 21. PMID: 38395096.
21.Hu Y, Jiang X, Li Y, Yang C, Ma M, Fang J, He L. Endovascular Treatment With or Without Intravenous Thrombolysis for Acute Ischemic Stroke Due to Tandem Occlusion: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2024 Sep 3;13(17):e034829. doi: 10.1161/JAHA.124.034829. Epub 2024 Aug 29. PMID: 39206729; PMCID: PMC11646517.
22.Tian T, Wang L, Xu J, Jia Y, Xue K, Huang S, Shen T, Luo Y, Li S, Min L. Prediction of early neurological deterioration in acute ischemic stroke patients treated with intravenous thrombolysis. J Cereb Blood Flow Metab. 2023 Dec;43(12):2049-2059. doi: 10.1177/0271678X231200117. Epub 2023 Sep 5. PMID: 37668997; PMCID: PMC10925869.
23.Du L, Zhang Y, Li X, Liu C, Li Z, Zhou J, Liu Y. Blood pressure excursion on admission and intravenous thrombolysis in ischemic stroke. J Hypertens. 2023 Aug 1;41(8):1265-1270. doi: 10.1097/HJH.0000000000003456. Epub 2023 May 19. PMID: 37199548; PMCID: PMC10328519.Wu L, Zheng Y, Ruan X, Wu D, Xu P, Liu J, Wu D, Li X. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs. 2022 Jan 1;33(1):e590-e603. doi: 10.1097/CAD.0000000000001189. PMID: 34338240; PMCID: PMC8670349.
24.Li Y, Li N, Zhou Y, Li L. Predicting ineffective thrombolysis in acute ischemic stroke with clinical and biochemical markers. Sci Rep. 2024 Jun 11;14(1):13424. doi: 10.1038/s41598-024-64413-w. PMID: 38862629; PMCID: PMC11166982.
25.Zhu HJ, Zhou SY, Qu Y, Sun YY, Zhang KJ, Pang SY, Yang Y, Guo ZN. Prognostic Value of Fibrosis-4 in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis. Clin Interv Aging. 2024 Oct 7;19:1663-1674. doi: 10.2147/CIA.S469899. PMID: 39398363; PMCID: PMC11468841.
26.Squizzato F, Zivelonghi C, Menegolo M, Xodo A, Colacchio EC, De Massari C, Grego F, Piazza M, Antonello M. A systematic review and meta-analysis on the outcomes of carotid endarterectomy after intravenous thrombolysis for acute ischemic stroke. J Vasc Surg. 2025 Jan;81(1):261-267.e2. doi: 10.1016/j.jvs.2024.08.014. Epub 2024 Aug 17. PMID: 39159889.
27.Du Y, Li Y, Duan Z, Ma C, Wang H, Liu R, Li S, Lian Y. The efficacy and safety of intravenous tirofiban in the treatment of acute ischemic stroke patients with early neurological deterioration. J Clin Pharm Ther. 2022 Dec;47(12):2350-2359. doi: 10.1111/jcpt.13816. Epub 2022 Dec 2. PMID: 36461632.
28.Zhan Z, Fu F, Zhang W, Cheng Z. Prevalence, Risk Factors, and Clinical Outcomes of New Cerebral Microbleeds After Intravenous Thrombolysis in Acute Ischemic Stroke: a Systematic Review and Meta-analysis. Clin Neuroradiol. 2024 Mar;34(1):209-218. doi: 10.1007/s00062-023-01357-0. Epub 2023 Oct 19. PMID: 37857916.
29.Wu L, Zhong Y, Yu X, Wu D, Xu P, Lv L, Ruan X, Liu Q, Feng Y, Liu J, Li X. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research. Anticancer Drugs. 2022 Oct 1;33(9):943-959. doi: 10.1097/CAD.0000000000001319. Epub 2022 Aug 9. PMID: 35946526; PMCID: PMC9481295.
30.Khan MO, Shah SA, Mahmood S, Aijaz A, Jatoi NN, Shakil F, Nusrat K, Siddiqui OM, Hameed I. Is endovascular treatment alone as effective and safe as that with preceding intravenous thrombolysis for acute ischemic stroke? A meta-analysis of randomized controlled trials. J Neurosurg Sci. 2024 Jun;68(3):338-347. doi: 10.23736/S0390-5616.23.06058-7. Epub 2023 Jun 30. PMID: 37389453.
31.Ding Y, Liu Y, Huang Q, Ma L, Tian Y, Zhou J, Niu J. Intravenous Thrombolysis Improves the Prognosis of Patients with Acute Ischemic Stroke and Chronic Kidney Disease. J Emerg Med. 2022 Aug;63(2):232-239. doi: 10.1016/j.jemermed.2022.05.013. Epub 2022 Aug 11. PMID: 35963783.
32.Man S, Solomon N, Mac Grory B, Alhanti B, Uchino K, Saver JL, Smith EE, Xian Y, Bhatt DL, Schwamm LH, Hussain MS, Fonarow GC. Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke. Circulation. 2023 Jul 4;148(1):20-34. doi: 10.1161/CIRCULATIONAHA.123.064053. Epub 2023 May 18. PMID: 37199147; PMCID: PMC10356148.
33.Wu L, Li H, Liu Y, Fan Z, Xu J, Li N, Qian X, Lin Z, Li X, Yan J. Research progress of 3D-bioprinted functional pancreas and in vitro tumor models. International Journal of Bioprinting. 2024, 10(1), 1256. doi: 10.36922/ijb.1256.
34.Vestergaard SB, Dahm CC, Gottrup H, Valentin JB, Johnsen SP, Andersen G, Mortensen JK. Intravenous thrombolysis for acute ischemic stroke is associated with lower risk of poststroke dementia: A nationwide cohort study. Eur Stroke J. 2023 Dec;8(4):947-955. doi: 10.1177/23969873231197530. Epub 2023 Sep 4. PMID: 37665134; PMCID: PMC10683737.
35.Elfil M, Ghaith HS, Elsayed H, Aladawi M, Elmashad A, Patel N, Medicherla C, El-Ghanem M, Amuluru K, Al-Mufti F. Intravenous thrombolysis plus mechanical thrombectomy versus mechanical thrombectomy alone for acute ischemic stroke: A systematic review and updated meta-analysis of clinical trials. Interv Neuroradiol. 2024 Aug;30(4):550-563. doi: 10.1177/15910199221140276. Epub 2022 Nov 28. PMID: 36437809; PMCID: PMC11483820.
36.Wu L, Li X, Qian X, Wang S, Liu J, Yan J. Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity. Vaccines (Basel). 2024 Feb 12;12(2):186. doi: 10.3390/vaccines12020186. PMID: 38400169; PMCID: PMC10891594.
37.Demeestere J, Qureshi MM, Vandewalle L, Wouters A, Strbian D, Nogueira RG, Nagel S, Yamagami H, Puetz V, Abdalkader M, Haussen DC, Mohammaden MH, Möhlenbruch MA, Olivé-Gadea M, Winzer S, Ribo M, Michel P, Marto JP, Tanaka K, Yoshimura S, Martinez-Majander N, Caparros F, Henon H, Tomppo L, Dusart A, Bellante F, Ramos JN, Jesser J, Sheth SA, Ortega-Gutiérrez S, Siegler JE, Nannoni S, Kaesmacher J, Dobrocky T, Salazar-Marioni S, Farooqui M, Virtanen P, Ventura R, Zaidi SF, Castonguay AC, Uchida K, Puri AS, Sakai N, Toyoda K, Farzin B, Masoud HE, Klein P, Bui J, Rizzo F, Kaiser DPO, Desfontaines P, Strambo D, Cordonnier C, Lin E, Ringleb PA, Roy D, Zaidat OO, Fischer U, Raymond J, Lemmens R, Nguyen TN. Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke. Stroke. 2024 Jul;55(7):1767-1775. doi: 10.1161/STROKEAHA.124.046495. Epub 2024 May 15. PMID: 38748598.
38.Hammed A, Al-Qiami A, Alzawahreh A, Rosenbauer J, Nada EA, Otmani Z, Hamam NG, Alnajjar AZ, Mohamed Hammad E, Hamamreh R, Kostev K, Richter G, Tanislav C. Comparative Effectiveness of Intravenous Thrombolysis plus Mechanical Thrombectomy versus Mechanical Thrombectomy Alone in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2025;54(4):603-616. doi: 10.1159/000541033. Epub 2024 Aug 24. PMID: 39182478.
39.Yang M, Tang L, Hu Z, Tang X. Application of Neuroimaging for the Prediction of Hemorrhagic Transformation after Intravenous Thrombolysis in Acute Ischemic Stroke. Cerebrovasc Dis. 2023;52(1):1-10. doi: 10.1159/000524749. Epub 2022 Jun 3. PMID: 35661647.
40.Aboulfotooh AM, Rizk H, El Serafy O, Ahmed SM, Soliman NM. Outcome of intravenous thrombolysis in acute ischemic stroke patients with small vessel disease. Clin Neurol Neurosurg. 2024 Nov;246:108570. doi: 10.1016/j.clineuro.2024.108570. Epub 2024 Oct 1. PMID: 39369479.
Copyright (c) 2025 Chunying Sun, Zongmei Liu, Hongling Qin, Fangcun Li, Ni Liang, Chao Gao, Wei Chen, Yueqiang Hu, Ding Zhang
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.